Genes coexpressed with DIP2B were also enriched in cell cycle-related pathways, including MITOTIC_SPINDLE, G2M_CHECKPOINT and E2F_TARGETS, which means that breast cancer cells with high expression of DIP2B showed stronger proliferative activity. The gene discussed is DIP2B; the disease is breast carcinoma.